Rebecca E Graff1,2, Gregory Judson3, Thomas U Ahearn1, Michelangelo Fiorentino1,4,5, Massimo Loda4,6, Edward L Giovannucci1,7,8, Lorelei A Mucci1,7, Andreas Pettersson1,9. 1. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 2. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California. 3. Department of Medicine, University of California San Francisco, San Francisco, California. 4. Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. 5. Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy. 6. Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. 7. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 8. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 9. Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Few studies have considered etiological differences across molecular subtypes of prostate cancer, despite potential to improve opportunities for precision prevention of a disease for which modifiable risk factors have remained elusive. Factors that lead to DNA double-strand breaks, such as oxidative stress, may promote the formation of the TMPRSS2:ERG gene fusion in prostate cancer. We tested the hypothesis that increasing levels of pre-diagnostic circulating antioxidants, which may reduce oxidative stress, are associated with lower risk of developing TMPRSS2:ERG positive prostate cancer. METHODS: We conducted a nested case-control study, including 370 cases and 2,470 controls, to evaluate associations between pre-diagnostic α- and β-carotene, α- and γ-tocopherol, β-cryptoxanthin, lutein, lycopene, retinol, and selenium with the risk of prostate cancer by ERG protein expression status (a marker of TMPRSS2:ERG). Multivariable unconditional polytomous logistic regression was used to calculate odds ratios and 95% confidence intervals. RESULTS: We did not find any of the antioxidants to be significantly associated with the risk of prostate cancer according to ERG status. CONCLUSIONS: The results do not support the hypothesis that circulating pre-diagnostic antioxidant levels protect against developing TMPRSS2:ERG positive prostate cancer. Additional studies are needed to explore mechanisms for the development of TMPRSS2:ERG positive disease. Prostate 77: 647-653, 2017.
RCT Entities:
BACKGROUND: Few studies have considered etiological differences across molecular subtypes of prostate cancer, despite potential to improve opportunities for precision prevention of a disease for which modifiable risk factors have remained elusive. Factors that lead to DNA double-strand breaks, such as oxidative stress, may promote the formation of the TMPRSS2:ERG gene fusion in prostate cancer. We tested the hypothesis that increasing levels of pre-diagnostic circulating antioxidants, which may reduce oxidative stress, are associated with lower risk of developing TMPRSS2:ERG positive prostate cancer. METHODS: We conducted a nested case-control study, including 370 cases and 2,470 controls, to evaluate associations between pre-diagnostic α- and β-carotene, α- and γ-tocopherol, β-cryptoxanthin, lutein, lycopene, retinol, and selenium with the risk of prostate cancer by ERG protein expression status (a marker of TMPRSS2:ERG). Multivariable unconditional polytomous logistic regression was used to calculate odds ratios and 95% confidence intervals. RESULTS: We did not find any of the antioxidants to be significantly associated with the risk of prostate cancer according to ERG status. CONCLUSIONS: The results do not support the hypothesis that circulating pre-diagnostic antioxidant levels protect against developing TMPRSS2:ERG positive prostate cancer. Additional studies are needed to explore mechanisms for the development of TMPRSS2:ERG positive disease. Prostate 77: 647-653, 2017.
Authors: Geert J L H van Leenders; Joost L Boormans; Cornelis J Vissers; A Marije Hoogland; Anke A J W M Bressers; Bungo Furusato; Jan Trapman Journal: Mod Pathol Date: 2011-04-15 Impact factor: 7.842
Authors: Alcides Chaux; Roula Albadine; Antoun Toubaji; Jessica Hicks; Alan Meeker; Elizabeth A Platz; Angelo M De Marzo; George J Netto Journal: Am J Surg Pathol Date: 2011-07 Impact factor: 6.394
Authors: Haojie Li; Meir J Stampfer; Edward L Giovannucci; J Steven Morris; Walter C Willett; J Michael Gaziano; Jing Ma Journal: J Natl Cancer Inst Date: 2004-05-05 Impact factor: 13.506
Authors: Rebecca E Graff; Andreas Pettersson; Rosina T Lis; Thomas U Ahearn; Sarah C Markt; Kathryn M Wilson; Jennifer R Rider; Michelangelo Fiorentino; Stephen Finn; Stacey A Kenfield; Massimo Loda; Edward L Giovannucci; Bernard Rosner; Lorelei A Mucci Journal: Am J Clin Nutr Date: 2016-01-27 Impact factor: 7.045
Authors: J L Wright; L Chéry; S Holt; D W Lin; M Luedeke; A E Rinckleb; C Maier; J L Stanford Journal: Prostate Cancer Prostatic Dis Date: 2015-10-27 Impact factor: 5.554
Authors: Timothy J Key; Paul N Appleby; Ruth C Travis; Demetrius Albanes; Anthony J Alberg; Aurelio Barricarte; Amanda Black; Heiner Boeing; H Bas Bueno-de-Mesquita; June M Chan; Chu Chen; Michael B Cook; Jenny L Donovan; Pilar Galan; Rebecca Gilbert; Graham G Giles; Edward Giovannucci; Gary E Goodman; Phyllis J Goodman; Marc J Gunter; Freddie C Hamdy; Markku Heliövaara; Kathy J Helzlsouer; Brian E Henderson; Serge Hercberg; Judy Hoffman-Bolton; Robert N Hoover; Mattias Johansson; Kay-Tee Khaw; Irena B King; Paul Knekt; Laurence N Kolonel; Loic Le Marchand; Satu Männistö; Richard M Martin; Haakon E Meyer; Alison M Mondul; Kristin A Moy; David E Neal; Marian L Neuhouser; Domenico Palli; Elizabeth A Platz; Camille Pouchieu; Harri Rissanen; Jeannette M Schenk; Gianluca Severi; Meir J Stampfer; Anne Tjønneland; Mathilde Touvier; Antonia Trichopoulou; Stephanie J Weinstein; Regina G Ziegler; Cindy Ke Zhou; Naomi E Allen Journal: Am J Clin Nutr Date: 2015-10-07 Impact factor: 7.045
Authors: Ivan M Petyaev; Pavel Y Dovgalevsky; Victor A Klochkov; Natalya E Chalyk; Dmitry V Pristensky; Marina P Chernyshova; Ruzan Udumyan; Taron Kocharyan; Nigel H Kyle; Marina V Lozbiakova; Yuriy K Bashmakov Journal: Food Sci Nutr Date: 2018-08-13 Impact factor: 2.863